Literature DB >> 17117951

Absence of association between two insertion/deletion coding genetic polymorphisms of TIM-1 gene and asthma in Chinese Han population.

J S Li1, Q J Liu, P Wang, H C Li, C H Wei, C H Guo, Y Q Gong.   

Abstract

TIM-1, a member of T-cell immunoglobulin domain and mucin domain (TIM) gene family, was implicated as an asthma susceptibility gene in previous studies. TIM-1 was expressed on CD4(+) T cells after activation and its expression was sustained preferentially in T-helper type 2 (T(H)2) but not in T(H)1 cells, therefore TIM-1 became a good candidate gene for atopic diseases. Recent studies indicated that two insertion/deletion (ins/del) coding genetic polymorphisms in exon 4 of TIM-1 were associated with asthma susceptibility in some but not in all populations. In order to investigate the relationship between TIM-1 genetic polymorphisms and asthma in Chinese Han population, we performed a case-control study for two insertion/deletion polymorphisms in TIM-1 exon 4 (5383_5397ins/del and 5509_5511delCAA) and a single nucleotide polymorphism (SNP) in intron 8 (IVS 8+9 G/A) between a healthy control group of 309 people and an asthma patient group of 352 people recruited from Chinese Han population. The polymorphisms were genotyped and the allele and genotype frequencies were analysed, but none of the three polymorphisms showed association with asthma susceptibility in single-locus association analyses. Linkage disequilibrium (LD) analyses demonstrated that the two insertion/deletion polymorphisms were in strong LD but the haplotypes constructed from these two polymorphisms showed no significant association with asthma. In conclusion, our findings suggest that 5383_5397ins/del, 5509_5511delCAA and SNP IVS 8+9 G/A polymorphisms are not associated with asthma susceptibility in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117951     DOI: 10.1111/j.1744-313X.2006.00634.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  8 in total

Review 1.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Associations of TIM-1 Genetic Polymorphisms with Asthma: A Meta-analysis.

Authors:  Xiaochuan Xie; Xiaohan Shi; Peng Chen; Li Rao
Journal:  Lung       Date:  2017-04-22       Impact factor: 2.584

3.  Pooled-analysis of the association between TIM-1 5383_5397 insertion/deletion polymorphism and asthma susceptibility.

Authors:  Jiangang Xu; Ping Jiang; Jiangbo Liu
Journal:  Mol Biol Rep       Date:  2014-08-26       Impact factor: 2.316

4.  Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases.

Authors:  José Raúl García-Lozano; Cristina Abad; Ana Escalera; Belén Torres; Olga Fernández; Alicia García; Julio Sánchez-Román; José-Mario Sabio; Norberto Ortego-Centeno; Enrique Raya-Alvarez; Antonio Núñez-Roldán; Javier Martín; María Francisca González-Escribano
Journal:  Hum Genet       Date:  2010-06-12       Impact factor: 4.132

5.  Are TIM proteins involved in asthma development or pathology?

Authors:  J Lin; L P Kane
Journal:  Clin Exp Allergy       Date:  2011-05-30       Impact factor: 5.018

Review 6.  TIM polymorphisms--genetics and function.

Authors:  J Lee; B Phong; A M Egloff; L P Kane
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

Review 7.  The role of the T-cell costimulatory molecule Tim-1 in the immune response.

Authors:  Miranda Curtiss; John Colgan
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case-control study.

Authors:  Ahlem Saadi; Guimin Gao; Huaichen Li; Chunhua Wei; Yaoqin Gong; Qiji Liu
Journal:  BMC Med Genet       Date:  2009-07-21       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.